All In Biotech

Drug Trial Radar · NCT06932068

Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma

Safety and Efficacy of Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for the Treatment of HER2-Negative, Low PD-L1 Expressing, Unresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Single-Arm Trial

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

77

Planned (sponsor's estimate)

Start

Mar 26, 2025

Primary completion

Oct 31, 2027

Study completion Oct 31, 2027

Sponsor

Lead sponsor
Qilu Hospital of Shandong UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is single - arm study to explore the safety and efficacy of iparomlimab and tuvonralimab (QL1706) combined with chemotherapy for treating her2-negative, low PD-L1 expressing, unresectable or metastatic gastric/gastroesophageal junction adenocarcinoma

Conditions

  • HER2 Negative
  • Low PD-L1 Expressing
  • Unresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Interventions

  • Iparomlimab and Tuvonralimab (QL1706)Drug

    5 mg/kg, ivdrip, Day 1, Q3W, until progressive disease or intolerable toxicity.

  • OxaliplatinDrug

    130 mg/m2, ivdrip, Day 1, Q3W, for the first 6 cycles.

  • Capectitabine TabletsDrug

    1000 mg/m2, po, bid, Days 1-14, Q3W, until progressive disease or intolerable toxicity.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. progression-free survival (PFS)Time frame: 12 months after the last subject participating in

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • Jining First People's Hospital

    Jining, China · Recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Recruiting

  • Binzhou Medical University Hospital

    Binzhou, Shandong, China · Recruiting

  • Dezhou People's Hospital

    Dezhou, Shandong, China · Recruiting

  • Shengli Oilfield Central Hospital

    Dongying, Shandong, China · Recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Recruiting

  • Shandong Provincial Hospital Affiliated to Shandong First Medical University

    Jinan, Shandong, China · Recruiting

  • Shandong Provincial Third Hospital

    Jinan, Shandong, China · Recruiting

  • Jinan Central Hospital

    Jinan, Shandong, China · Recruiting

  • Jinan Third People's Hospital

    Jinan, Shandong, China · Recruiting

  • Shandong Qianfoshan Hospital

    Jinan, Shandong, China · Recruiting

  • Affiliated Hospital of Jining Medical College

    Jining, Shandong, China · Recruiting

  • Liaocheng People's Hospital

    Liaocheng, Shandong, China · Recruiting

  • Linyi Cancer Hospital

    Linyi, Shandong, China · Recruiting

  • Linyi People's Hospital

    Linyi, Shandong, China · Recruiting

  • Qilu Hospital of Shandong University(Qingdao)

    Qingdao, Shandong, China · Recruiting

  • Qingdao Municipal Hospital

    Qingdao, Shandong, China · Recruiting

  • Qingdao Municipal Hospital

    Qingdao, Shandong, China · Recruiting

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, China · Recruiting

  • Taian City Central Hospital

    Tai’an, Shandong, China · Recruiting

  • The Second Affiliated Hospital of Shandong First Medical University

    Tai’an, Shandong, China · Recruiting

  • Tengzhou Central People's Hospital

    Tengzhou, Shandong, China · Recruiting

  • Weifang Hospital of Traditional Chinese Medicine

    Weifang, Shandong, China · Recruiting

  • Weihai Central Hospital

    Weihai, Shandong, China · Recruiting

  • Yantai Yuhuangding Hospital

    Yantai, Shandong, China · Recruiting

  • Yantai Yuhuangding Hospital

    Yantai, Shandong, China · Recruiting

  • Yantaishan Hospital

    Yantai, Shandong, China · Recruiting

  • Zibo Central Hospital

    Zibo, Shandong, China · Recruiting

  • Zibo First People's Hospital

    Zibo, Shandong, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.